Organisation

GUIDE Institute for Drug Exploration, part of the Groningen Graduate...

Pagina-navigatie:

Main
Completed research (38)

Completed research

(the most recent research is at the top)
Secretariat	Host defense against tumour growth
Secretariat	Infection and inflammation research
Secretariat	Autoimmunity research
Secretariat	Transplantation research
Secretariat	Transplantation, immunology, inflammation
Secretariat	Analysis of biomarkers
Secretariat	Affinity-based protein enrichment
Secretariat	High-resolution separation technology
Secretariat	Renal diseases
Secretariat	Pharmacoepidemiology and drug policy
Secretariat	Oncology
Secretariat	Liver, gastrointestinal and metabolic diseases
Secretariat	Cardiovascular diseases
Secretariat	Biopharmaceuticals: discovery, design and delivery
Secretariat	Asthma / COPD
Secretariat	Regulation of the immune response in man and rat by factors associated with reproduction
Secretariat	Cytokine profiles of foreign body reactions against (biodegradable) biomaterials
Secretariat	Tissue engineering of vascular grafts using endothelial progenitor cells
Secretariat	Modulation of foreign body reactions against biodegradable biomaterials: the role of the formation and activation of giant cells
Secretariat	Tissue engineering of cardiac tissue using neonatal cardiomyocytes or bone marrow cells
Secretariat	Application of viral immune evasion proteins to inhibit organ rejection after transplantation
Secretariat	The search for genes and their function using bioinformatics (primers design, gene localisation, marker development)
Secretariat	The search for genes for complex diseases
Secretariat	Development of transgenic animal models for disease
Secretariat	The initiation of transplant damage in brain death donors
Secretariat	Epithelial damage in transplanted tracheas
Secretariat	Early risk factors for chronic rejection after lung transplantation
Secretariat	The role of surfactant on the function of a transplanted lung
Secretariat	Modulation of apoptosis induction for transplant rejection
Secretariat	Vasculature directed therapies for the treatment of cancer and chronic inflammatory diseases
Secretariat	Role of sphingolipids in immune homeostasis as a basis for treatment of cancer or transplant rejection
Secretariat	Development of bispecific antibodies for immunotherapy of non-Hodgkin lymphoma
Secretariat	Development of recombinant bifunctional proteins for immunotherapy of carcinomas
Secretariat	Pharmaceutical technology and industrial pharmacy
Secretariat	Pharmaceutical biology
Secretariat	Pharmacokinetics and drug delivery
Secretariat	Therapeutic gene modulation
Secretariat	Chemotherapy for patients with colorectal cancer. Potential contributions by the clinical pharmacist